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CHAPTER I
INTRODUCTION
Research Motivation
Liver transplantation has become the standard of care for end-stage liver disease in the 
United States in the past  two decades.  During this time however, the waiting list  of candidates 
awaiting transplantation has increased dramatically, while the size of the organ donor pool has 
increased more slowly [1,2].  As shown in figure 1, the national allocation system is currently not 
in equilibrium, with the quantity of liver grafts demanded exceeding the available supply.  As a 
result of this deficit, more than 2,000 patients die annually while awaiting liver transplantation. 
Liver transplantation ranks among the most  expensive medical services available, costing 
hundreds of thousands of dollars [3].  In light of the scarcity of both organs and money, careful 
allocation of liver grafts is critical in order to maximize survival and quality of life for liver 
transplant patients.  
History of Liver Transplantation
The first  successful human liver transplant was performed by Dr. Thomas Starzl in 1967. 
The surgical foundation necessary for liver transplantation had been established, but 
underdeveloped technology for immunosuppression made long-term survival after liver 
transplantation rare during the 1960’s and 1970’s.  Because of this, liver transplantation remained 
an experimental form of therapy until the 1980’s.  The advent  of cyclosporine represented a 
breakthrough for liver transplantation, and it became a successful and established form of 
treatment. 
In 1984, the U.S. Congress passed the National Organ Transplant Act  (NOTA) [4].  It 
specified the framework for a national system of organ transplantation.  Among its other 
provisions, it  called for the establishment of the Organ Procurement and Transplantation Network 
1
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(OPTN), which represents the logistical infrastructure for transplantation in this country.  On 
September 30, 1986, the United Network for Organ Sharing (UNOS) was awarded the initial 
contract to administer the OPTN, and the contract has been continuously renewed to the present 
time [5].  The UNOS is responsible to facilitate the matching of organ donors and recipients, to 
collect data for every transplant  that occurs in the country, and to develop organ transplantation 
policy.  
At the present time there are 122 health care institutions in the country currently offering 
liver transplantation, and a total of 6,164 transplants were performed in 2004 alone [2].  There are 
currently more than 18,000 candidates awaiting liver transplantation.  Approximately 95% of all 
liver transplants performed use cadaveric liver grafts.  While living donor liver transplantation is 
technically possible, this widespread use of this technique has been limited in part  by the risk to 
the donor.  Thus, the procurement of cadaveric livers is the primary limitation on the number of 
liver transplants that  can be performed.  
Allocation Policy
The current mechanism for allocating cadaveric livers is based on the Model for End-
Stage Liver Disease (MELD) [6,7].  It was implemented in February 2002, with the goal of 
creating a “sickest-first” system in which the patients could be ranked by an objective, continuous 
scale according to the severity of liver disease.  Changes in allocation policy are made by the 
UNOS, with oversight  from the U.S. Department of Health and Human Services.  
The UNOS provides a framework of principles for making policy decisions about  organ 
allocation.  There are two specific and sometimes competing goals that must be considered for 
decision making in transplantation: Utility and Justice [8].  Utility is defined as “allocating organs 
to those individuals who will make the ‘best’ use of them,” and Justice is defined as “allocation of 
organs to those patients in the most immediate need.”  The UNOS Liver Committee proposes 
allocation policy in accordance with these goals.  Policy changes are proposed based upon a 
3
combination of the clinical expertise of the committee members and experimental inference 
provided by the Scientific Registry of Transplant Recipients (SRTR).  
Predicting Outcomes
A means to help clinicians and policy-makers predict  the outcomes of liver 
transplantation could prove beneficial both in the clinical and in the research setting.  For clinical 
purposes, a model with good predictive ability may help to distinguish between transplants most 
likely to result  in good outcomes and transplants most  likely to result in poor outcomes.  Avoiding 
futility in transplantation was noted in the desiderata for an organ allocation system [9].  If even a 
small percentage of futile transplants could be avoided each year, the effect  on outcomes of 
patients receiving liver transplants could be substantial both in terms of life-years saved and 
quality of life gained.  
Furthermore, when a liver graft  is offered to a transplant center, clinicians may need to 
select among multiple candidates, all of whom are eligible for the donor liver.  A good survival 
model could be employed to aid matching between donors and recipients.  Beyond the issue of 
the liver shortage, a survival model could also help select the ideal course of therapy for 
individual patients.  Some patients might experience greater benefit from treatments other than 
transplantation, such as hepatic resection or medical therapy, and a survival model may help 
clinicians to identify these patients.  Thus, individual transplant  centers could use a survival 
model as an adjunct  to clinical judgment in selecting candidates for transplantation.  
Finally on the research side, the SRTR is responsible for answering inferential requests 
from the UNOS.  An accurate survival model could help policy-makers to assess a priori the 
likely effects of proposed changes in policy.  For instance, a model could be employed as a 
component  of a simulation process to model the aggregate effects of changes in allocation policy, 
before the changes are implemented.  Because the utility of a survival model lies in its ability to 
make predictions at the time of decision-making – that is, just  prior to transplantation – this thesis 
will focus on pre-transplant models.
4
A variety of measures exist to evaluate the success of a liver transplant.  The measures 
most common to the field are patient survival and graft survival.  Patient  survival refers to the 
amount of time that  a patient lives following the date of transplantation, while graft survival is 
defined as the number of days from transplantation to either patient death or retransplantation. 
Functional performance, as manifested by a patient’s ability to perform the activities of daily 
living or return to work, can be used to represent  the quality of life achieved after transplantation 
[10].  Patients may also report  on health-related quality of life using a variety of instruments, such 
as the SF-36 inventory [11].  Quality-adjusted life years could be used to measure patient  survival 
and quality of life simultaneously.  
When dealing with the problem of allocation, the goal is to optimize the utilization of 
scarce cadaveric organs.  Thus, focusing on graft survival allows one to consider both the life of 
the patient and the use of an organ.  The Kaplan-Meier survival curve for graft  survival following 
liver transplantation, shown in figure 2, reveals a steep decline in the number of survivors in the 
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Figure 2.  Kaplan-Meier graft survival after liver transplantation, 1995-2000.  As illustrated, many of the deaths and 
retransplantations occur in the early post-operative period, and the survival rate stabilizes after a few months.  The 
red line marks the 90-day anniversary of transplantation.  
early post-operative period.  As time progresses after transplantation, the slope of the curve 
flattens and stabilizes.  Because of this, 90-day graft survival was adopted as the outcome metric 
of interest for this thesis.  
Specific Aims
Aim 1: To determine whether informatics techniques can improve upon Cox regression in 
predicting outcomes following liver transplantation. 
Aim 2: To simplify the machine learning model by identifying the key factors necessary for 
robust prediction of outcomes. 
Aim 3: To evaluate the practical significance of a refined model in a clinical setting. 
The motivation and context  for the proposed research is described in Chapter I.  Chapter 
II describes a systematic literature review to identify the relevant  literature on modeling survival 
after liver transplantation.  Chapter III presents methodology that  will be shared by multiple 
studies in this thesis.  The following four chapters detail the experiments that  address the Specific 
Aims.  Chapter IV presents a Bayesian network model that  was created and validated to address 
Specific Aim 1.  Chapter V describes a variable selection experiment, which will address Specific 
Aim 2.  Chapter VI examines the complexity of the problem in a manner that  partially addresses 
both Specific Aims 1 and 2.  Chapter VII describes research on how well clinicians predict 
survival in comparison to mathematical models.  The practical significance of a survival model 
lies in its ability to improve upon the current  standard of care, which is the use of clinical 
judgment to predict survival.  In this way, the study will address Specific Aim 3.  The thesis 
concludes in Chapter VIII with a discussion of the key findings, together with the resulting policy 
implications.  
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CHAPTER II
SYSTEMATIC LITERATURE REVIEW
Purpose
The goal of the systematic literature review was to identify articles dealing with the use 
of statistical models to predict  survival after liver transplantation.  I will note the strengths and 
weaknesses of articles written to address this problem.  The research described later in this thesis 
will represent an effort to address the gaps that  are identified in the body of past research.  
Methods
Relevant articles were defined to be those “dealing with the creation or validation of a 
general, pre-transplant, human, adult, statistical model to predict graft  or patient survival 
following liver transplantation.”  Terms within this definition were defined by the following: 
“General” was defined to refer to a model that was intended for use on the whole 
population of adult liver transplant recipients, rather than a specific sub-population based on 
disease etiology or retransplantation.  When studies listed specific exclusion criteria, such as 
patients with fulminant hepatic failure, the studies were deemed relevant  as long as the exceptions 
represented a minority of transplants performed.  
“Pre-transplant” was defined to refer to a model that  could be evaluated at  the time of 
transplantation; in other words, it  does not  require the availability of intra-operative or post-
operative information.  
“Statistical model” was defined as a mathematical entity that  was created or used for the 
purpose of making predictions.  
Articles that adhere to the above definition should address three general concepts: (1) 
liver transplantation in humans, (2) an outcome measure, and (3) statistical modeling.  I identified 
all possible medical subject heading (MeSH) terms that fell into any of the three categories using 
7
the MeSH browser [12].  These three concepts, together with the MeSH terms that apply to them 
are described as follows:
The concept of liver transplantation in humans was described by the MeSH terms "Liver 
Transplantation" and "Humans".
The concept  of an outcome measure was described by the MeSH terms "Treatment 
Outcome"; “Survival Rate"; "Graft  Survival"; "Prognosis"; "Mortality"; "Liver Transplantation/
mortality"; “Host vs Graft  Reaction"; "Graft  Rejection"; and "Graft Survival".
The concept of statistical modeling was described by the MeSH terms "Proportional 
Hazards Models"; "Neural Networks (Computer)"; "Models, Statistical"; "Survival Analysis"; 
"Models, Theoretical"; "Computing Methodologies"; "Artificial Intelligence"; and "Bayes 
Theorem".
I traced the set  of MeSH terms up the hierarchy and identified common parents whenever 
possible, with the goal of making the search very broad and thorough.  Lastly, the search was 
limited to English articles that  were published prior to March 31, 2005.  No beginning publication 
date for the search was specified.  The final PubMed search strings are shown in table 1.  
Two reviewers independently examined all abstracts returned by the search and identified 
all potentially relevant  articles using the title and abstract.  Disagreement  was resolved by 
8
Table 1. PubMed search strings for systematic literature review on 8/25/2005
Search String # of Abstracts
1. Search "Liver Transplantation"[MeSH] 25494
2. Search #1 AND "Humans"[MeSH] 21753
3. Search #2 AND ("Mortality"[MeSH] OR "Liver Transplantation/mortality"[MeSH] OR 
"Survival"[MeSH] OR "Prognosis"[MeSH] OR "Host vs Graft Reaction"[MeSH]) 8094
4. Search #2 AND ("Statistics"[MeSH] OR "Models, Theoretical"[MeSH] OR "Computing 
Methodologies"[MeSH]) 3782
5. Search #3 AND #4 2112
6. Search #5 AND "English"[la] 1980
7. Search #6 AND Limit Publication Date up to 2005/03/31 1937
Note: Search #7 denotes the final set of abstracts examined by the reviewers. 
consensus opinion.  When the correct  classification was ambiguous based solely on the abstract, it 
was included for examination of the full-text  article.
The full-text  articles were retrieved, and their relevance was examined to obtain the final 
list of articles that fit the inclusion definition provided above.  Aspects of the methodology of 
each article were abstracted: (1) the data source used, (2) the model validated, (3) the 
performance measure used; and for articles that created an original model, (4) the modeling 
technique used, and (5) the experimental design for validation. 
Results
The PubMed search described above returned 1937 abstracts.  The two reviewers 
narrowed the list  to 49 abstracts for which the full-text was retrieved.  After review of the full-text 
articles, 22 fit  the inclusion criteria 
[13-34].  The relevant  articles are 
summarized in table 2.  Among 
these articles, 10 focused on 
validating existing models that had 
been created for other purposes, and 
the remaining 12 detailed the 
creation of original models.  Three 
of the articles were published 
before 2000, and the remaining 19 
articles were published between 
2000-2005, as shown in figure 3. 
Data Sources
Eight  of the relevant  articles used a large multi-center data source, and 15 used data from 
a single transplanting institution.  One study created a model using data from a single center and 
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Figure 3.  Relevant articles by year of publication.  Recent 
years have seen a growing number of articles published on the 
use of models to predict survival after liver transplantation.  
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then validated it using data from a multi-center database.  The median sample size used, in 
number of transplant  events, was 228 (range: 31-827) for the single-center studies and 11,878 
(range: 1,510-38,876) for the multi-center studies.  Five of the multi-center studies used data from 
the UNOS, two used data from the UK and Ireland Liver Transplant Audit, and one used data 
from the European Liver Transplant Registry.  
Models
Existing models that were validated by a number of articles included MELD (9 articles), 
Child-Turcotte-Pugh (CTP) score (2 articles), and UNOS status (2 articles).  Other existing 
indexes were each validated for survival prediction in one article and included Acute Physiology 
and Chronic Health Evaluation (APACHE) II/III, Canadian Waitlisting Algorithm in 
Transplantation (CanWAIT), Child-Pugh class, Simplified Acute Physiology Score (SAPS), delta-
MELD, and activation status.  
Among the articles that dealt  with the creation of original models, various techniques of 
statistical modeling were used, including Cox proportional hazards regression (5 articles), logistic 
regression (2 articles), neural networks (2 articles), product-limit estimate (1 article), non-specific 
risk profile (1 article), and “trial-and-error” (1 article).  
Validation
The relevant studies used various methods of model validation.  Among the studies that 
created original models, five used the same data set for model derivation and validation, six used 
an independent data set for model validation, and one performed no validation.  The validation 
statistics employed included measures of simple association (8 articles), discriminatory power (8 
articles) including area under the receiver operating characteristic curve (AUC) [35], operating 
characteristics (2 articles), aggregate mortality (2 articles), and qualitative “separation” (1 article).  
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Synopses
Brief synopses of the relevant articles follow, in chronological order of publication.  The 
first  model to predict survival after liver transplantation was reported by Shaw et  al. in 1985 [13]. 
They used a cohort  of patients transplanted at Pittsburgh to identify key risk factors and develop 
an empirical scoring system using “trial-and-error”. They assessed the prognostic value of their 
model for 6-month survival by qualitatively assessing the “separation” attained.  
Maggi et al. established the predictive value of the traditional Child-Pugh classification 
with a set of patients transplanted in Milan, Italy [14].  They found no significant difference in 
survival between patients of the three Child-Pugh classifications A, B, and C at an alpha level of 
0.01, and concluded that  no definite prognostic value of the Child-Pugh classification could yet 
be assigned.  
Selberg et  al. assessed the ability of nutritional and metabolic parameters to predict 
outcomes of liver transplantation [15].  They studied transplant candidates at the Medical School 
of Hannover, Germany and noted that resting energy expenditure and body cell mass could be 
used as a “risk profile” that  showed a significant  difference in terms of Kaplan-Meier survival 
curves.  
Chung et al. correlated pre-transplant  activation status, SAPS, and APACHE II/III with 
post-transplant survival [16].  Activation status was defined as a four-category ordinal variable 
that denoted whether a patient was at  home, in the hospital, in intensive care, or being 
mechanically ventilated at the time an organ was offered.  They studied 31 patients transplanted at 
Vancouver Hospital in Canada, and found no significant  correlation between any of the risk 
scores and survival.  They concluded that  detailed physiological scoring systems were of no 
greater value in predicting outcome than activation status.  
Adam et  al. used patients from the European Liver Transplant  Registry to develop two 
original models [17].  Their adult  model is described below, and their pediatric model was not 
relevant to the present  study.  They selected variables using Cox regression and derived the model 
using the product-limit estimate.  The model included 11 variables and 8 two-way interactions 
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between variables.  They concluded that  the “normalized intrinsic mortality risk” predicted by the 
model was similar to that seen in the whole population. 
Parmanto and Doyle used recurrent  neural networks trained with the backpropagation-
through-time algorithm to predict 90-day graft  survival for adults transplanted at Pittsburgh [18]. 
They validated the model by 6-fold cross validation, and reported model performance in terms of 
“total performance”, defined as (sensitivity + specificity) / 2.   They developed a series of models 
beginning at  the time of transplantation, and sequentially including 1, 2, 3, 4, 5, and 6 post-
operative days.  They showed that model performance improves with each day of post-operative 
information provided, and nearly perfect classifications, in terms of the total performance metric, 
may be made with 6 days of post-operative information.  
Ghobrial et al. expanded on a model that  had been previously developed to predict 
survival in hepatitis C patients [19].  They used the UNOS database and Cox regression to 
develop an 8-factor model that included recipient age, donor age, creatinine, total bilirubin, 
prothrombin time, retransplantation, cold ischemia time, and warm ischemia time.  They 
validated the model with the same data used to derive the model and reported c-statistics of 0.69, 
0.68, and 0.67 for 3-month, 6-month, and 1-year patient  survival, respectively.  
Onaca et  al. validated the use of the pre-transplant  MELD score to predict  mortality 
within 2 years after transplantation [20].  They studied patients who underwent transplantation at 
Baylor in Dallas, Texas.  The patients were divided into strata of MELD < 15, MELD 15-24, and 
MELD > 24.  They were also categorized by disease: hepatitis C, cholestatic liver disease, and 
non-cholestatic liver disease.  They found significant  differences in survival at  3, 6, 12, 18, and 24 
months for patients in the high MELD strata.  
Fernandez-Aguilar et al. examined the use of the MELD score and CTP score in 
predicting post-transplant  survival [21].  They included adults receiving liver transplants at a 
single hospital in Spain.  Using the chi-square test, a MELD score ≥ 18 was not  significantly 
associated with 1-year survival, but a CTP  score ≥ 10 was significant  at an alpha level of 0.01. 
They concluded that  the MELD score adds no prognostic advantage to the CTP score.  
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Saab et  al. assessed the association of MELD with 1-year patient  survival on a cohort of 
adult  liver transplant recipients at  the University of California in Los Angeles [22].  They used 
Cox regression for the purpose of identifying independent risk factors of mortality and 
demonstrated an independent  association between MELD strata and outcome.  
Thuluvath et  al. developed “user-friendly” models to predict  post-transplant  survival [23]. 
They used a very large cohort  of patients from the UNOS database and used 2/3 of them, 
randomly selected, to derive logistic regression models, and the remaining 1/3 to validate the 
models.  They converted the regression coefficients of the resulting models into integers that 
could be added to obtain a “severity score” ranging from 1 to 30.  This calculation was easy to 
perform by hand, hence their designation as a “user-friendly” model.  Their models for 1-month 
and 1-year patient survival included age, body mass index, UNOS status, diagnosis, total 
bilirubin, and creatinine.  Their model for 5-year patient  survival included race in addition to the 
other predictors.  They reported AUC values of 0.7, 0.7, and 0.63 for 1 month, 1 year, and 5 years, 
respectively.    
Bilbao et al. reviewed the literature for predictors of post-transplant survival after liver 
transplantation [24].  They developed an original model using patients transplanted in Barcelona, 
Spain.  They used logistic regression to predict  3-month patient survival using four variables: 
Child-Pugh class, renal insufficiency, need for cross-clamping, and malnutrition.  The model 
operating characteristics were 75% sensitivity, 75% specificity, 30% positive predictive value, 
and 94.4% negative predictive value on the training set; and 80% sensitivity, 88% specificity, 
61.5% positive predictive value, and 95.3% negative predictive value on an independent 
validation set.  
Desai et  al. used MELD and an original model to predict  survival [25].  They used 
patients from the UNOS database to create a Cox regression model that included age, ventilation, 
dialysis, and retransplantation.  They reported an AUC performance for 3-month survival of 0.54 
(95% confidence interval [CI]: 0.50-0.59) for MELD.  Their original model achieved AUC 
14
performance of 0.65 (95% CI: 0.61-0.69) on the training set  and 0.60 (95% CI: 0.58-0.63 on the 
validation set. 
 Santori et al. evaluated the use of UNOS status and MELD score for predicting patient 
survival at 3 months [26].  They examined patients who were transplanted in Genoa, Italy, and 
reported c-statistics of 0.524 (95% CI: 0.410-0.636) for UNOS status and 0.677 (95% CI: 
0.527-0.762) for MELD.  There was no significant  difference between the c-statistics for UNOS 
status and MELD score.  
 Austin et  al. examined whether there was a difference in mortality between veterans and 
non-veterans after liver transplantation [27].  They compared two cohorts of patients receiving 
liver transplants at Oregon Health & Science University, including 285 university patients and 
149 veterans.  Their initial analysis found that  veteran status was not  a significant predictor of 
outcome.  Next  they created a Cox proportional hazards model using the entire study cohort that 
included gender, donor age, recipient  age, and MELD score.  They also created an alternate 
model that  avoided the politically charged variables of recipient  age and gender, and this model 
included donor age, alcoholism, and MELD score.  They validated the models using the study 
cohort for predicting 1-year graft  survival and reported an AUC of 0.71 for the 4-variable model 
and 0.66 for the 3-variable model.  
Roberts et  al. created a library of disease-specific models to predict post-liver transplant 
survival [28].  They used a cohort of patients from the UNOS database and grouped patients into 
disease categories determined by the National Clinical Oversight Committee.  They built Cox 
regression models for each of ten disease categories.  The models showed that different variables 
were significant predictors for different diseases. They compared model-predicted Kaplan-Meier 
survival curves for a standardized patient with actual Kaplan-Meier survival curves and noted 
similarity between the two.  They concluded that disease etiology is a stronger predictor of 
outcome than MELD score.  
 Jacob et  al. assessed the ability of the MELD score to predict  90-day patient survival 
[29].  They used data from the UK and Ireland Liver Transplant  Audit  and evaluated predictive 
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ability of the model using the c-statistic.  They also re-estimated the coefficients of MELD using 
Cox regression and validated the modified model.  The c-statistic for MELD was 0.58 (95% CI: 
0.54-0.61), and this value remained less than 0.60 after re-estimating coefficients and considering 
non-linearity.  They concluded that the MELD score might  be appropriate to predict pre-
transplant outcomes but not  post-transplant outcomes.  
Bazarah et al. compared the ability of the MELD score, the CTP score, and CanWAIT  to 
predict post-transplant  survival [30].  They used patients transplanted at  the Queen Elizabeth II 
Health Sciences Hospital in Canada.  They noted significant  correlations between all three 
models’ predictions and 90-day graft survival.  They calculated c-statistics of 0.67 for MELD, 
0.65 for CTP score, and 0.71 for CanWAIT.  They concluded that there is no substantiated reason 
to consider replacing the currently used CanWAIT system for liver transplantation in Canada.  
Northup et al. evaluated the utility of pre-transplant delta-MELD score as a predictor of 
post-transplant survival [31].  The delta-MELD score was defined as the change in a patient’s 
MELD score during the 30 days prior to transplantation.  They examined liver transplant 
recipients from the UNOS database.  Using logistic regression, they concluded that absolute 
MELD score was significantly associated with 90-day survival, but delta-MELD was not. 
Santori et  al. compared UNOS status with the MELD score for predicting patient  survival 
at  1 month, 3 months, 6 months, and 1 year; and graft survival at 1 week, 1 month, 3 months, 6, 
months, and 1 year [32].  This was similar in nature to their 2004 study described above, except 
that their study cohort  was reduced and they examined additional endpoints. They assessed 
performance by AUC, and performance of both models at almost all endpoints was less than 0.6. 
They reported a trend of better performance for the MELD score, but  this was not  statistically 
significant.  
Haydon et al. used self-organizing maps, a variant  of neural networks, to predict 
transplant survival [33].  They studied patients transplanted at Queen Elizabeth Hospital in the 
United Kingdom.  Their network contained 37 recipient and 18 donor variables, and it  was 
trained to predict  3-month and 1-year patient  survival.  The model was validated using a national 
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multi-center database, and they showed that  there was a significant difference by chi-square test 
in survival for the different  output  neurons.  
 Moore et  al. simplified previous survival models that  had been reported in the literature 
[34].  They studied patients that  underwent liver transplantation at Vanderbilt University Medical 
Center.  They used Cox regression to identify three recipient, donor, and technical factors as 
independent  predictors of graft and patient survival: UNOS status 1/2A versus 2B/3, donor age ≥ 
60 years, and cold ischemia time ≥ 12 hours. 
Discussion
The literature review included 22 articles published between 1985 and 2005.  Recent 
years have seen a surge of interest in predicting survival after liver transplantation, possibly due 
to the increasing scarcity of liver grafts.  Great  diversity exists among the articles discussed in 
terms of data sources and methodology employed.  Survival modeling is well developed in the 
literature using Cox regression and logistic regression.  A variety of machine learning techniques 
exist  for developing statistical models, yet  only two papers have used neural networks [18,33], 
and no papers have reported the use of other established techniques.  Despite the efforts that 
researchers have made, no well-validated survival model currently exists with discriminatory 
power greater than 0.7 AUC.  
One limitation of the present  review is that I did not  judge the quality of the studies 
discussed.  This review instead focused on a historical summary of methodology, because a 
review has already been reported that  incorporated qualitative judgment of each article [36]. 
Jacob et al. performed a systematic literature review similar to ours, except that  after identifying 
the body of relevant literature, they used an assessment tool to judge the quality of the studies. 
The tool was based on published instruments and was modified for the purpose of their review 
[37].  Using the tool, they found that  five articles fulfilled the instrument’s quality criteria to be 
included in the review [17,19,23-25].  Of the models in these articles, three were based in the 
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United States and therefore can be easily re-evaluated using the UNOS data set  [19,23,25].  These 
three models will be used later in this research for the purpose of comparative validation.  
My research will represent  an attempt  to improve upon past  research in two specific 
ways.  First, all methods of statistical modeling make certain assumptions about  the data or the 
underlying process that generated them, and models perform optimally when those assumptions 
hold true.  The Cox assumptions are not stringent, and the successful use of such techniques is 
widespread in the medical literature.  However, the computational approaches germane to 
informatics allow for great  flexibility and power in selecting model hypotheses, possibly resulting 
in improved performance.  Thus, freedom from the assumptions inherent  in Cox regression may 
allow for the construction of improved models for post-transplant outcomes using alternative 
techniques.  Second, careful validation of a survival model is essential if conclusions are to be 
made about  its generalizable performance.  Not all models proposed in the literature were 
externally validated, and this may lead to overly optimistic conclusions about  model performance. 
Conclusion
Various pre-existing and original models have been employed to try to predict  survival 
after liver transplantation.  However, there may be room for improvement in the performance of 
these proposed models [36].  The use of established techniques from machine learning has not 
been thoroughly explored in this context.  Furthermore, the validation techniques employed for 
some published models may limit  the conclusions that  may be made about  their generalizable 
performance.  
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CHAPTER III
GENERAL METHODOLOGY
The UNOS Database
The UNOS operates the national system for organ transplantation.  As mandated by 
policy, all transplanting institutions must report certain information for each transplant  performed. 
The UNOS Liver Committee selects the relevant  set of variables to be reported, which are 
collected on standardized forms made available by the UNOS.  The UNOS makes the information 
publicly available in a de-identified electronic format.  The UNOS database was selected for my 
research, which was approved by the local Institutional Review Board (IRB #040419: “Liver 
Transplant  Outcomes: Bayesian Analysis and Other Artificial Intelligence Techniques”).  
The provided distribution of the UNOS database contains 372 fields for 62,676 
transplants, representing every liver transplant performed in the country since the mid-1980’s. 
The precise beginning date is unknown, because all of the dates contained are consistently shifted 
by an unknown amount, plus or minus six months.  The UNOS database is large and 
comprehensive; however, certain aspects made it  challenging to work with.  As common for 
large-scale databases, the included elements need to be examined for errors and inconsistencies. 
For one patient, the wrong scale appears to have been used when the height was reported to be 
1.85 centimeters, rather than 1.85 meters.  Another patient  was reported to have a survival time of 
negative 91 days.  Moreover, many fields in the database contain varying proportions of missing 
values, and the reason for this is unknown.  
Moreover, there is a selection bias inherent  in the UNOS database, because each patient 
is selected for transplantation not  randomly, but  according to a specific allocation policy.  Those 
candidates deemed by clinicians to be too sick for transplantation are removed from the waiting 
list, and thus are not represented in the set  of transplant events.  Despite some limitations, the 
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UNOS database was considered to be the best available information source for my experiments, 
due to its large sample size compared with single-center databases.  
Database Scrubbing
All variables were inspected and cleaned prior to analysis using a Perl script.  Every data 
field was verified to contain interpretable information.  In other words, each field in the database 
was verified to contain a number where expected; a string of the form MM/DD/YYYY where a 
date was expected; or a string of the form HH:MM:SS where a time was expected.  Many fields 
contained meaningless information; for example, many binary yes/no variables were marked ‘U’ 
or ‘Uncertain’.  Similarly, some serological tests were marked as ‘Indeterminate’ or ‘Cannot 
Disclose’.  Ambiguous or meaningless values were treated as if they were missing.  
Discrete variables with many categories were abstracted into fewer categories in a 
clinically justifiable fashion, thus allowing for larger sample sizes within each category.  For 
example, the home state of the donor, which was represented by more than 50 categories, was 
consolidated into 11 transplant regions defined by the UNOS.  Range checking was performed for 
all continuous variables to verify that  they lay within a reasonable range, determined by clinical 
experts, and outliers were removed and as missing values.  As an example, all ages were ensured 
to be non-negative values.  Complete details of the database cleaning process can be found in 
appendix A.  
Overview of Modeling Techniques
The following is a brief survey of major statistical modeling techniques, each of which 
has its own strengths and weaknesses.  As discussed previously, many studies in the literature 
proposed Cox regression models to predict  liver transplant  survival [19,25,27,28,34].  The use of 
machine learning modeling techniques, some of which have different or more relaxed 
assumptions than Cox regression, or which do not  require a priori preference for some functional 
form, may result in improved performance for the prediction of liver transplant outcomes.  A 
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variety of modeling techniques exist  in the field of machine learning, and these have been 
successful in a variety of tasks ranging from stock market prediction to facial recognition [38-39]. 
Machine learning methods have also been applied successfully to some difficult  problems in 
medicine, such as classification and prognosis of cancer for example [40].  
Cox Proportional Hazards Regression
The Cox proportional hazards model has experienced widespread application in 
predicting survival.  Three central assumptions exist  in this regression technique [41]:  
The linearity assumption states that the relationship between a predictor and the outcome 
takes a linear functional form.  For variables that  have a skewed distribution, as laboratory values 
commonly do, the axis may be transformed by a square root  or logarithmic function so that  the 
transformed variable may adhere better to the linearity assumption.  
The additivity assumption states that  the total effect  of different  predictors may be 
estimated simply by summing the individual effects.  In cases where a more complex variable 
interaction is believed to exist, the experimenter may create a composite variable by joining two 
individual variables together in a single term.  
The proportional hazards assumption states that the impact of each predictor on survival 
does not change over time.  Extensions to the Cox model exist, such as the use of time-dependent 
covariates, to allow for situations where this assumption does not hold [42].  
In summary, the Cox assumptions are not  rigid, and some methods exist  to account for 
situations when they are violated.  These methods tend to require a priori preference for some 
functional form by the experimenter.  
Decision Trees
A decision tree is a schematic of sequential decisions that  branch to arrive at  some 
outcome [43-44].  A decision tree can be easily represented by a flowchart, in which each node 
involves testing some condition, and the path of questions followed subsequently depends on the 
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answer to each question before it, until some conclusion node is reached.  This series of steps 
allows a decision tree to make inferences based on data.  A variety of algorithms exist  for 
constructing a decision tree from raw data, and for the most part  decision trees tend to generate 
models in accordance with Occam’s Razor, preferring simpler explanations over more complex 
ones.1  
Decision trees have the advantage that  they lead to human-interpretable models. 
However, they also have a tendency to generate models that over-fit  a given data set, although 
pruning mechanisms may be used to simplify a decision tree to combat  this shortcoming. 
Moreover, decision trees assume that the data set  can be appropriately split at  every node by 
considering only one data feature.  This assumption does not  hold for many complex problems.  
Bayesian Models
Bayesian reasoning takes a probabilistic approach to model induction.  It is founded on 
the principle that, given a set  of attributes together with prior conditional probabilities, Bayes’ 
theorem is used to assign a certain probability to various hypotheses [45].  Bayesian methods tend 
to operate more efficiently if the input data are discrete.  Many techniques exist to convert 
continuous variables into discrete ones, and the choice of discretization technique may have a 
large impact  on model performance [46].  The Bayesian approach to modeling is tolerant  to 
missing data values.  Different  flavors of Bayesian modeling exist: the naïve Bayesian classifier, 
the optimal Bayesian classifier, and Bayesian networks [43].  
A naïve Bayesian classifier assumes that various outcomes are mutually exclusive, and 
that the effects of all predictors are conditionally independent of all other predictors.  While these 
assumptions seem relatively stringent, the naïve Bayesian classifier has been shown to perform 
very well in many circumstances [47].  
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1 William of Occam, a 14th century English friar,  is generally credited for the principle, “Entia non sunt multiplicanda 
praeter necessitatem.”  Loosely interpreted, this means that when facing multiple explanations, all other things being 
equal, the simpler one should be preferred.  
The optimal Bayesian classifier relaxes the assumptions of the naïve Bayesian classifier, 
but its need for a huge table of conditional probabilities means that  it may only achieve optimality 
with a nearly infinite sample size, and with nearly infinite computational power to estimate the 
probabilities.  Because of this, the optimal Bayesian classifier is impractical to use for many 
complex problems [48].  
A Bayesian network represents a structure of statistical associations between variables, so 
it creates a human-interpretable directed acyclic graph of relationships.  A conditional probability 
table is populated for each node in the network.  A Bayesian network assumes that  the data are 
generated from a faithful distribution, which means that there is a Bayesian network structure that 
can describe the joint  distribution [49,50].  
k-Nearest Neighbors
The k-nearest neighbors algorithm takes a set  of known data points, and it  makes a 
decision about an unknown data point  using the k data points closest to the unknown point 
[43,51].  It  operates under the assumption that the appropriate prediction for a given data point is 
denoted by the outcomes of data points “nearest” to it.  In this regard, it  has some common 
ground with clustering techniques.  A variety of distance measures may be employed.  The most 
common approach is to plot  all data points in hyperspace and measure the Euclidean distance 
between them to determine their similarity.  
This assumes that  every dimension in the set  of features is equally important in making a 
prediction for novel data.  This is known as the “curse of dimensionality” [52], and is considered 
to be a major weakness in k-nearest neighbors modeling.  To compensate for the curse of 
dimensionality, some extensions have been proposed that  involve weighting individual axes 
according to their impact  in predicting the outcome.  Moreover, the k-nearest neighbors algorithm 
assumes that the scale of every axis in the data is identical, and this assumption may be satisfied 
by normalizing and scaling each variable.  Lastly, this technique does not  tolerate missing data, so 
either missing fields must be imputed, or data points with missing variables must be eliminated.  
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Neural Networks
Neural networks are inspired by the biological process of neurons in the brain [43,53].  A 
given neuron fires a signal when it  is stimulated above some threshold.  Its output may be sent to 
other neurons, where it has a stimulatory or inhibitory effect on each of the neurons that  it 
innervates.  Collectively, a network of such neurons may exhibit  complex reactions to different 
stimuli.  The presentation of various stimuli over time, together with a feedback mechanism, 
results in those neurons being trained for certain responses.  The computational analog of this 
process can result  in the creation of highly complex but powerful models.  Artificial neurons may 
be combined in multiple layers or other structures as desired for some learning task.  
The chief assumption in neural networks is that  of reinforcement learning – repeated 
presentation of some stimulus to a neuron, as manifest by patterns in a data set, will result in the 
pattern becoming recognizable to the network [54].  Otherwise, neural networks are relatively 
free from assumptions about the functional form of a model.  A network with at  least two layers 
and adequate neurons within each layer is capable of learning any arbitrary function.  
The power of neural networks carries with it  certain disadvantages – first, neural 
networks are very prone to over-fitting; and second, the model becomes a “black box” that shows 
predictive power without  revealing useful information about  the underlying process [55]. 
Missing data may be either imputed or encoded using dummy input neurons for each variable. 
Moreover, multiple local optima may be encountered in the training process, potentially 
preventing the model from achieving a globally optimal state.  Finally, training a neural network 
may be extremely intensive from a computational standpoint.  
Support Vector Machines
Support  vector machines are a relatively novel and very popular development in the 
machine learning community [56,57].  They have achieved success in many modeling tasks, and 
they rectify some shortcomings of neural networks.  A support vector machine plots data points in 
multi-dimensional space and draws a separating hyperplane to distinguish between various 
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outcomes.  This space need not be linear, and various functional forms may be modeled through 
the use of kernel functions.  The selection of a kernel function represents an a priori preference 
for some functional form, although these functions are quite versatile and hence not very 
restrictive.  Kernel functions implicitly map each data point into a transformed, higher-
dimensional space.  This mapping is implicit  because, due to the use of mathematical identities, 
the precise location of each data point is not  calculated – only the dot  product  of two vectors in 
the transformed space must  be known.  
The support vector machine formulation has a unique optimum, and training always 
converges at this optimum.  Due to the implicit transformation of input data, this optimum may be 
solved in a computationally efficient manner.  Moreover, support vector machines perform 
relatively well in the context of noisy data.  However, like neural networks they have the 
disadvantage of being a “black box” – a model may perform very well while revealing little 
explanatory information about  the process that it is modeling.  Also similar to neural networks, 
missing values must be either imputed or encoded using dummy variables.  
Experimental Design
Statistical modeling experiments must  be carefully designed in order to make conclusions 
about the generalizability of resulting models.  When a model is derived using one data set and 
validated using that  same data set, valid conclusions may be drawn about how well the model fits 
that data set; i.e., the experimenters may conclude that “our model fits these data with x predictive 
ability.”  However, no conclusions may be drawn regarding the generalizability of the model; that 
is, how well the model can make predictions based on unforeseen data points.  When the 
experimenter wishes to assert that “our model fits other data with x predictive ability” – as is 
often the case in research involving statistical modeling – different approaches must  be used.  
Two experimental designs that  can be employed to reach conclusions about  model 
generalizability are cross-validation and independent validation [58].  Cross-validation refers to 
the process of taking a single set of data and randomly dividing it  into a number of balanced 
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splits, with each containing a representative sample of the whole data set.  The first  split  is 
designated the validation set, and all of the other splits are used as a training set.  A model is 
derived using the training set, and its performance is estimated using the validation set.  Next, the 
second split is designated as the validation set, and all other splits as the training set.  The process 
is repeated once for each of the splits, so that each split serves as a validation set  once during the 
experiment.  The process of cross-validation can be further extended to include an inner 
optimization loop when parameters must be selected for a modeling technique.  The inner loop 
involves using a nested experiment of cross-validation on each of the training sets employed, thus 
allowing the model parameters to be selected in a manner that is relatively free of bias.  The final 
result of a cross-validated experiment  is generally reported as an average of performance for all 
splits. 
Independent validation refers to the process of generating a model using a training set, 
and then validating the model using an independent  source of data.  The data may come from a 
different  population, a different  time, or a different  geographical location.  For example, a model 
to predict  survival after liver transplantation could be derived using data from the United States 
and subsequently validated using data from Europe.  This would allow the researcher to conclude 
that the observed model performance does not depend on a specific process that is unique to the 
United States.  Consequently, there would be reason to believe that the model will perform 
similarly when presented with other previously unseen data.  
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CHAPTER IV
BAYESIAN NETWORK
Purpose
I am unaware of previous attempts to use Bayesian networks to model outcomes 
following liver transplantation.  The purpose of the present experiment  was to evaluate the 
feasibility and suitability of Bayesian networks for predicting 90-day graft survival.  I 
hypothesize that  a Bayesian network can be created using expert  knowledge in the field of liver 
transplantation to model post-transplant  survival, and that this Bayesian network will have better 
discriminatory power than other survival models in the literature.  
Methods
This study included all liver transplant  events in the UNOS database occurring between 
2000-2002, and which involved an adult (≥ 18 years) recipient  and an adult donor (n = 12,239). 
Some patients received multiple liver grafts, and thus may be represented in the data by more 
than one transplant  event.  The binary outcome variable of interest was 90-day graft survival, 
where the endpoint of graft survival is defined as death or retransplantation.  Transplant events 
were eliminated if the patient  was lost to follow-up prior to 90 days (n = 132).  A set  of 258 
variables in the database were identified as being available by the time of transplantation, so these 
were used as independent variables in the pool of candidate predictors for survival.  These factors 
included demographic information, such as recipient  and donor age, gender, and race; clinical 
information, such as laboratory values, medical condition, and functional status; and technical 
information, such as cold and warm ischemia time.  
As described briefly in the general methodology (Chapter III), a Bayesian network 
describes a system of interest by specifying relationships of conditional dependence between its 
variables [43,49,50].  These relationships are represented by a directed acyclic graph, and this, 
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together with a joint  probability distribution for the nodes it  contains, creates a model that can be 
used for making inferences.  Bayesian networks are being used for a variety of medical problems 
that involve reasoning with uncertainty.  For example, Heckerman et al. developed a system to aid 
in diagnosis of diseases of the lymph nodes [59].  Domain knowledge drawn from clinical 
expertise and relevant literature was used to select  key predictors of survival from the pool of 
available pre-transplant variables, and subsequently to construct the relationships between nodes 
in the network [24,60,61].   
All data processing and performance analysis was done with Matlab (version 6.5, http://
www.mathworks.com), while the Bayesian network was created and simulated using the Netica 
development  environment  (version 1.12, http://www.norsys.com).  Different  network structures 
were examined to determine the appropriate degree of model complexity.  Both continuous and 
discrete variables were represented in the network, and all continuous variables were discretized 
into seven equal-width intervals.  The Netica software tolerates missing values in data, so no 
imputation was performed.  
I employed a three-fold cross-validated experimental design.  All data points from 
2000-2001 were randomly split  into three stratified folds.  Three iterations of model training and 
validation were conducted, each time estimating model parameters using two-thirds of the data 
and determining its performance using the remaining third.  A final model was created using all 
data points from 2000 and 2001, and I validated its performance using an independent set 
consisting of the data from 2002.  
Model performance was determined using the receiver operating characteristic (ROC) 
curve.  This curve plots the sensitivity and 1 - specificity levels achieved across all possible 
thresholds in a binary classification task.  The AUC represents the overall discrimination power 
of a given test, where a value of 0.5 denotes random guessing and 1.0 demonstrates perfect 
classification [35].  All AUC analyses was performed using ROCKIT  (http://www-
radiology.uchicago.edu/krl/KRL_ROC/software_index.htm).  For the final independent validation 
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step, I calculated AUC as well as 
specificity and positive and negative 
predictive value for fixed sensitivity levels 
of 95% and 90%.  
To compare the performance of 
my Bayesian network to other models 
published in the literature, I selected three 
Cox regression models from the literature 
[19,23,25].  These studies were used 
because they were identified as “high-
quality” articles in a recent systematic 
literature review [36].  I ran the 
independent  validation set  from 2002 
through these three models.  Because these 
models are not  tolerant to missing data, I imputed missing values in the independent validation set 
using close linear surrogates where possible.2   For other variables no linear surrogate was 
available, so I used mean imputation to fill in the other missing values.  The discriminatory power 
of these models was estimated in terms of AUC.  I performed three pairwise comparisons of AUC 
between the Bayesian network and each of the other three models.  The Bonferroni correction 
was applied to the significance level as appropriate, resulting in an alpha level of 0.0033.  
Results
The descriptive statistics from some key variables in the data set  were compared between 
the study populations from 2000-2001 and 2002, and they are summarized in table 3.  The 
proportion of patients achieving 90-day graft  survival improved between 2000-2001 and 2002. 
The age of patients receiving liver transplants was not  significantly different between the two 
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2 Specifically, when necessary, prothrombin time was estimated by multiplying the international normalized ratio by a 
factor of 12.  
Table 3. Demographics of the study population
2000-2001
(n = 7,887)
2002
(n = 4,220)
90-Day Graft Survival*
   Yes
   No
Age
   Mean ± SD (in years)
Gender*
   Female
   Male
Diagnosis*
   Acute Hepatic Necrosis
   Cholestatic
   Malignant
   Metabolic
   Non-Cholestatic
   Other
86.6%
13.4%
50.8 ± 10.0
34.7%
65.3%
8.6%
11.0%
3.6%
3.0%
68.5%
5.3%
89.2%
10.8%
51.1 ± 9.7
31.2%
68.8%
6.7%
10.8%
7.8%
2.7%
66.6%
5.4%
Note: Data represent transplant events, so unique 
patients may be represented more than once.  Asterisk 
denotes a significant difference between the 
populations from 2000-2001 and 2002, p < 0.01.
groups.  Gender of liver transplant patients showed a small but statistically significant difference 
in favor of more males being transplanted in 2002.  The diagnostic categories were mostly similar 
between the two study populations, excepting that  the percentage of patients being transplanted 
for malignancy doubled from 2000-2001 to 2002.  In both groups, non-cholestatic liver disease, 
including alcoholic liver disease and hepatitis C, accounted for a significant  majority of liver 
transplants performed.  
The Bayesian network consisted of 30 nodes, including 29 nodes representing pre-
transplant variables and a single dichotomous outcome node for 90-day graft  survival.  Only 
seven of the most important predictors of survival were designated as parents of the outcome 
node, ensuring that  its conditional probability table would not  grow too large and contain many 
structural zeros.  The other nodes in the network were connected either as grandparents or as 
children of the outcome node, and the relationships between different predictor nodes were 
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Figure 4. Structure of the final  Bayesian network, created using domain knowledge from clinical expertise and 
literature review.  The outcome node is shown in  the center and is highlighted with pink.  Recipient variables are 
shown in blue, donor variables are shown in green, and technical variables are shown in orange.  
founded on clinical rationale.  A total of 39 links connected the network, and the joint  probability 
distribution across all nodes consisted of 2,049 conditional probabilities.  The final network 
structure is shown in figure 4.  
The mean performance of the three cross-validated folds as measured by AUC was 0.674, 
and the AUC for the independent 
validation set  was 0.681 (95% CI: 
0.654-0.707).  The ROC curves are 
shown superimposed in figure 5. 
Using a threshold that fixed the 
sensitivity level at  95%, the model 
specificity was 18%, with a positive 
predictive value of 91% and a 
negative predictive value of 30%. 
These operating characteristics are 
31
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
1 - specificity
S
en
si
ti
v
it
y
Area under curve (95% CI)
Split 1 0.659 (0.628-0.689)
Split 2 0.681 (0.650-0.711)
Split 3 0.682 (0.651-0.712)
Independent 0.681 (0.654-0.707)
Figure 5.  Receiver operating characteristic curves of Bayesian network performance.  Area under curve values are 
shown for the three cross-validated splits using the training set from 2000-2001, as well as for the independent 
validation set from 2002, shown in red.
Table 4. Bayesian network classification at fixed 95% sensitivity
Actual outcome
Survivor Non-survivor
Predicted 
outcome
Survivor 3578 373
Non-survivor 188 81
Sensitivity:
Specificity:
Positive Predictive Value:
Negative Predictive Value:
Likelihood Ratio (+):
Likelihood Ratio (–):
95% (fixed)
18%
91%
30%
1.16
0.28
summarized in table 4.  When the sensitivity level was fixed at 90%, the resulting specificity was 
27%, and the positive predictive value remained at  91% while the negative predictive value was 
24%.  
The AUC performance for predicting 90-day graft  survival was 0.617 (95% CI:
0.588-0.646) for the Desai model, 0.616 (95% CI: 0.588-0.643) for the Ghobrial model, and 
0.605 (95% CI: 0.576-0.633) for the Thuluvath model.  Multiple pairwise comparisons of the 
alpha level between my model and each of the three others showed that  the Bayesian network had 
significantly greater discriminatory power than the others (p < 0.0033).  The ROC curves from 
the four models on the independent validation set are shown in figure 6.  
Discussion
A Bayesian network model may be constructed using domain expertise to predict 
outcomes following liver transplantation.  My network for predicting 90-day graft  survival 
performed modestly well, according to the AUC.  Performance was found to be highly consistent 
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Figure 6.  Receiver operating characteristic curves of comparative model performance.  The Bayesian network and 
three models from the literature were validated using the same independent data set from 2002.  Asterisks denote 
statistical significance in a pairwise comparison of AUC versus the Bayesian network, p < 0.0033.
between the training and independent  validation sets.  Model performance was also examined 
using a fixed threshold that  yielded a sensitivity level of 95%, and the resulting specificity level 
was low.  The model showed a very good positive predictive value (91%), whereas the negative 
predictive value was relatively low.  I interpreted this to mean that  the model performs very well 
at  the task of identifying good survivors.  However, the model does not  perform well at 
recognizing poor survival candidates for liver transplantation.  One limitation of the study is that 
132 transplant events were eliminated from analysis due to inadequate follow-up information; it 
is plausible that many of these represented poor outcomes, so a bias may have been introduced to 
the research.  
Of noteworthy mention is the fact  that  the UNOS instituted a major allocation policy 
change in February, 2002, by switching from a ranking of four sickness categories – Status 1, 2A, 
2B, and 3 – to using a continuous scale called MELD [6,7].  This policy change closely coincided 
with the division between the training set from 2000-2001 and the independent  validation set 
from 2002.  This observation may explain why differences were seen in certain descriptive 
statistics as noted above.  Regardless, since performance was very consistent between both study 
groups despite the policy change, this suggests that  the Bayesian network model may generalize 
well.  
The performance of the Bayesian network measured by AUC was approximately 5-10% 
higher than previous Cox regression models in the literature, and this difference was statistically 
significant [19,23,25].  Furthermore, because I used a data set that  was independent  with respect 
to all four models, I was able to perform a well-controlled comparative validation to show that  the 
Bayesian network outperforms the others in predicting 90-day graft survival.  This conclusion is 
worded carefully and is not  intended to impugn the quality of the other models or the studies that 
created them. 
The present research sheds new light on the field of modeling liver transplant outcomes 
in a few ways.  First, to my knowledge Bayesian networks have not previously been applied to 
the problem of modeling liver transplant outcomes.  The use of this technique may better lend 
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itself to high model complexity than Cox regression does, as evidenced by the 29 predictors 
included in the Bayesian network model.   Another benefit to this modeling technique, as 
compared with Cox regression, is that  Bayesian analysis is tolerant  to missing values such that no 
imputation is necessary.  Moreover, by examining the positive and negative predictive value of 
the model, I found that  the difficult part of the problem lies not in identifying good survivors, but 
in identifying poor survivors.  Lastly, my model incorporates some interactions between 
important  predictors, and while it  is possible to explicitly specify variable interactions in a Cox 
regression model, none of the models used for comparison included them.  
Future research will focus on constructing a Bayesian network that  incorporates both pre-
transplant information as well as some early post-transplant  information.  The model can be 
trained with joint  probability distribution governing all nodes in the network, even if inferences 
are made by entering findings only into pre-transplant  nodes.  The presence of this additional 
information in the network may help improve predictive power. 
Conclusion
 Bayesian networks may be used to model graft  survival following liver transplantation 
with fair performance.  This model exhibited greater discriminatory power than three other high-
quality models from the literature.  The Bayesian network is a candidate for further validation 
using foreign liver transplant data.  Given its high positive predictive value, our model may serve 
as a useful adjunct to clinical judgment in identifying patients most  likely to have good outcomes.  
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CHAPTER V
VARIABLE SELECTION
Purpose
Selecting variables for predicting liver transplant survival has traditionally relied upon 
clinical judgment for a priori selection of variables, followed by statistical treatment  of this 
subset to empirically identify the most important  factors.  Computational techniques for feature 
selection may be used to obtain the minimal set of variables required for optimal prediction, 
called the “Markov blanket” [62].  The goal of this study was to compare the performance of 
survival models created from factors chosen using traditional methods versus those selected by an 
automated technique that  approximates the Markov blanket.  I evaluated the performance of these 
predictor sets using several different  types of machine learning models.
Methods
Four different sets of predictors from the UNOS liver transplant database were used to 
model 90-day graft survival in adult (> 18 years) liver transplant  recipients.  The variables 
identified by Desai [25], Ghobrial [19], and Thuluvath [23] were used as baseline predictor sets, 
derived via well-established methods of univariate and multivariate association.   
Among all of the pre-transplant  variables in the UNOS database, 148 of them were at 
least 80% populated for the study period from 1995-1999.  Variables with a greater fraction of 
missing information were deemed to have insufficient data for further analysis.  These variables 
were available at  the time of transplantation, and any of them could be potential predictors for 
post-transplant outcomes.  
The automated feature selection technique used repeated tests of conditional 
independence with forward and backward conditioning to identify key features in the data set.  An 
alpha level of 0.001 was used for all statistical tests in automated feature selection, both for entry 
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into and exit from the variable pool.   This technique was based on the algorithm described by 
Aliferis et  al., and I refer the reader to the original paper for more technical details [63].  My 
method differed from theirs in that  I did not  implement the final wrapper step specified in their 
algorithm.  For the feature selection step, continuous variables were discretized by selecting 
thresholds that maximized the chi-squared association with the outcome variable.  Once all 
variables were in the required discrete form, missing values were encoded as a separate category.
Various types of classifier models were built  to predict 90-day graft  survival; specifically 
linear regression, naïve Bayesian classifiers, support  vector machines, and neural networks.  To 
ensure that  all required values were populated in the data set, I excluded data points that  had 
values missing for any of the required variables in the four predictor sets.  All of the feature 
selection and modeling experiments were conducted using the Matlab environment. (version 6.5, 
http://www.mathworks.com)
I employed a 3-fold cross-validated experimental design using the data set  from 
1995-1999 (n = 6,765).  The data were randomly divided into balanced splits, and during three 
alternating iterations two of these splits were used to train a model, while the third was used to 
validate the model.  I also created a final model using the entire data set from 1995-1999, and 
validated its performance using an independent  data set of adults transplanted from 2000-2002 (n 
= 2,119).  The AUC was used to assess model performance [35].  This metric quantifies 
discriminatory power, where 0.5 denotes random guessing and 1.0 denotes perfect  discrimination. 
I repeated the cross-validation step five times to obtain an average AUC for each predictor set and 
model type.  I used a t-test  to evaluate the difference between the means between my predictor set 
and those published in the literature.  
To evaluate the necessity of all predictors, a support  vector machine was trained with 
random fractions of features removed from the predictor set.  I repeated the above process of 
cross-validation five times with all predictors in the set; five times with 25% of the predictors 
randomly selected for removal; five times with 50% of the predictors randomly selected for 
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removal; and five times with 75% of the predictors randomly selected for removal.  The results 
were visualized using a scatterplot.  
Results
The automated feature selection technique selected 21 survival predictors, cross-tabulated 
in table 5.  All of these predictors were clinically justifiable, and some of them had not been used 
in the other models from the literature.  The linear regression, naïve Bayes, and support  vector 
machine models tended to show better performance for all predictor sets than the neural network, 
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Table 5. Comparison of four predictor sets for liver transplant survival
Predictor Desai Ghobrial Thuluvath Automated
Recipient Variables
   Age, recipient
   Diagnosis of liver disease
   Serum creatinine
   Total bilirubin
   Prothrombin time
   UNOS status, registration
   UNOS status, transplantation
   Medical condition, registration
   Medical condition, transplantation
   Dialysis, registration
   Dialysis, transplantation
   Life support, transplantation
   On ventilator, transplantation
   Previous abdominal surgery
   Previous liver transplant
   Previous primary non-function
   Date of transplant referral
   Days on waiting list
   Employment status
   Body mass index
   Racial background
Donor Variables
   Age, donor
   Whole or split liver graft
Technical Variables
   UNOS region
   Cold ischemia time
   Warm ischemia time
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
as seen in table 6.  For these three model types, my predictor set outperformed each of the three 
others by cross-validation (p < 0.0001).  Similar trends were seen by prospective validation, 
except  for the Ghobrial predictor set, which showed similar performance to my predictor set.  
Moreover, when increasing numbers of variables were randomly removed from my 
predictor set, a gradual decline in support  vector machine performance was seen.  The variability 
of model discriminatory power also became greater as more variables were removed.  These 
trends are shown on a scatterplot in figure 7. 
Discussion
Key predictive factors for liver transplant  survival may be identified in a very large 
database using fully automated methods.  My feature set  was mostly a superset of the three other 
sets from the literature; i.e. it included nearly all of the features that the others used, but  it  also 
incorporated some additional variables.  Validation showed that my technique led to the creation 
of models with statistically better performance than two out  of three baseline data sets.  The 
improved performance may in part  be due to the fact that  my predictor set contained more 
information than the other sets; it  contained 21 predictors while the others had 8, 4, and 7 
predictors.  Moreover, this predictor set  does not depend on a specific type of model to perform 
well, as different machine learning techniques all resulted in the creation of similarly performing 
models.  Future experiments may further reduce the size of the predictor set while maintaining 
predictive power.
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Table 6. Model performance with four different predictor sets
Model Type Desai Ghobrial Thuluvath Automated
Logistic regression
Naïve Bayes
Neural network
Support vector
0.63* (0.62)
0.62* (0.60)
0.58 (0.56)
0.63* (0.62)
0.65* (0.65)
0.64* (0.61)
0.64 (0.60)
0.65* (0.65)
0.64* (0.63)
0.63* (0.60)
0.61 (0.59)
0.63* (0.62)
0.67 (0.64)
0.67 (0.63)
0.63 (0.62)
0.68 (0.65)
Note: Performance is  measured by AUC, with independent  validation in parentheses. 
Asterisk denotes predictor sets that were outperformed by the automated set, p < 0.0001. 
Conclusion
Fully automated feature selection techniques may be used to identify the key predictors 
of liver transplant survival from a very large database, and this predictor set  performed better than 
two out of three other predictor sets reported in the literature.  Furthermore, various machine 
learning techniques may be used in conjunction with the UNOS database to model survival 
following liver transplantation.  
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Figure 7.  Impact of randomly deleting variables from the automated predictor set.  All models in this experiment 
were support vector machines.  Each data point represents the mean performance of one cross-validated experiment 
with a specified fraction of variables randomly removed.  Discriminatory power was measured by the area under the 
receiver operating characteristic curve.  A minor impact on model performance was observed when 25-50% of the 
variables were removed from the predictor set, and a greater impact on performance was observed when 75% were 
removed.  
CHAPTER VI
COMPLEXITY ANALYSIS
Purpose
As described previously, support vector machines have been growing in popularity for 
machine learning applications due to their mathematical elegance and computational efficiency 
[57].  They can detect patterns in large data sets consisting of hundreds or thousands of variables. 
The support  vector machine formulation is based upon an implicit  mapping of variables to a 
higher-dimensional space through the use of kernel functions.  When a polynomial function is 
used as the kernel function, all possible variable interactions up to an arbitrary complexity are 
implicitly considered for the model [56].  For example, a polynomial support vector machine of 
degree two would implicitly model all main effects and all possible combinations of two-variable 
interactions.  
The goal of this experiment was to evaluate the ability of support vector machines to 
predict liver transplant  outcomes using the entire set of pre-transplant variables available in the 
UNOS database.  To my knowledge, no previously reported model has incorporated all available 
information in the UNOS database.  It  is possible that some variables available in the pre-
transplant database have previously been overlooked, and they might contain useful information 
for modeling.  A second goal of the experiment was to determine the extent  to which complex 
variable interactions are important for predicting liver transplant survival.  
Methods
The population for this study was all adult  (> 18 years) liver transplant  recipients in the 
UNOS database from 1995-1999 (n = 15,747).  All of the 258 available pre-transplant variables, 
described earlier, were included in the data set.  Two copies of the data set were created, and they 
differed in the way missing values were handled.  For one data set  – called the missing-encoded 
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data set – all missing values were set to 0.  For every variable in the data set, an additional 
dummy variable was created, and this dummy variable held the value 0 if the corresponding value 
was missing and 1 if it  was populated.  For the second data set, the missing-imputed data set, all 
missing values were filled in using the sample mean of all populated values for that variable. 
Both data sets were processed according to the technique described earlier in the general 
methodology chapter.  Continuous values were normalized and scaled between 0 and 1, and 
discrete variables with more than two categories were distributed into multiple binary variables.  
The GEMS software package was used for model creation and validation [64].  GEMS 
automates the process of optimizing and cross-validating a model through a graphical user 
interface.  Using both the missing-encoded and missing-imputed data sets, I conducted a 3-fold 
cross-validated experiment, using an inner loop to optimize the support vector machine tolerance 
and kernel parameters.  Next, I conducted another experiment using the missing-imputed data set. 
All support vector machine parameters were fixed, including tolerance, and I varied the degree of 
the polynomial kernel function.  Ten models were created, one for every integer degree from 1 to 
10.  Discriminatory power for all generated models was measured using the area under the 
receiver operating characteristic curve, and the relationship between polynomial degree and AUC 
was visualized using a line graph [35].  
Results
The discriminatory power was similar for the missing-encoded (AUC = 0.666) and the 
missing-imputed (AUC = 0.661) data sets.  When polynomial degree was varied and other 
parameters remained fixed, the AUC of the support vector machine increased from 0.605 to 0.654 
as the degree was increased from 1 to 2.  However, using polynomial kernel functions of degree 
higher than 2, the model discriminatory power remained virtually constant  all the way up to 
degree 10, as seen in figure 8.  
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Discussion
A survival model was constructed with the entire set  of available pre-transplant 
information, using a support vector machine.  Given that the missing-encoded and missing-
imputed data sets performed similarly, the support vector machine does not  seem to be learning 
patterns of reporting in the data.  If the model performance on the missing-encoded data set  had 
significantly exceeded model performance on the missing-imputed data set, questions would have 
been raised about whether the data alone, or the data combined with the reporting habits of 
transplant centers, was providing information about post-transplant survival.  
The effect  of degree of the polynomial kernel function on model performance was 
striking due to the sharp rise in performance between degrees 1 and 2, and the stable performance 
at  all degrees greater than 2.  This observation implies that little or no marginal benefit exists in 
considering interactions involving more than two variables.  A limitation of the present  study 
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Figure 8.  Effect of polynomial kernel degree on support vector machine performance.  The degree of the kernel 
function determines the complexity of the space into which the input is mapped.  It may be roughly interpreted as an 
unknown space in which all possible interactions up to some determined size are considered.  Discriminatory power 
was measured by the area under the receiver operating characteristic curve.  Note that the vertical axis does not 
range from 0 to 1, in order to allow easier visualization of results.  
exists in that  the polynomial kernel function of degree 2 implicitly considers both main effects 
that are non-linear in shape, as well as two-way interactions between variables.  Thus, one cannot 
conclude which of the two factors accounted for the rise in performance between degrees 1 and 2: 
whether two-way interactions, or non-linear functions of main effects.  Another limitation of the 
experiment lies in the fact  that the support vector machine remains a “black box” in the sense that 
these results do not provide information about which specific variables or interactions of 
variables are important  for the model.  However, the results illustrate that complex interactions 
involving three or more variables may not need to be considered for post-transplant  survival 
modeling using the UNOS database. 
Conclusion
A support vector machine can be trained to predict  post-transplant  survival using the 
entire set  of pre-transplant  variables available in the UNOS database.  Moreover, complex 
interactions involving more than two variables may not need to be taken into account for 
predicting liver transplant  survival when using this database.
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CHAPTER VII
CLINICIAN SURVEY
Purpose
Clinical judgment is the current standard for making decisions about liver transplant 
allocation.  This raises the question, how good are clinicians in predicting outcomes following 
liver transplantation?  In other fields, studies have been published to assess the predictive ability 
of clinicians.  In oncology, a systematic literature review showed that for terminally ill cancer 
patients, clinicians were found to overestimate survival consistently [65].  Despite this poor 
calibration, their predictions were highly correlated with actual survival.  Thus, clinician 
predictions did have some discriminatory power.  Critical care physicians were found to have 
difficulty predicting length of stay in ICU patients whose total length of stay was greater than five 
days [66].  However, for patients with a short  length of stay in the ICU, physicians were able to 
predict the length of stay and outcome fairly accurately, with more experienced clinicians 
showing better performance than their less experienced colleagues.  
I am aware of no previous studies that assessed the prognostic ability of clinicians in the 
field of liver transplantation.  The purpose of the present study is to quantify the ability of expert 
clinicians to predict outcomes after liver transplantation, and to compare the clinicians’ 
performance to published survival models. 
Methods
Survey Participants
The local Institutional Review Board approved this research (IRB #050329, “Assessing 
Clinical Utility of a Liver Transplant  Survival Model”).  I invited clinicians at  different  transplant 
centers specializing in the care of liver transplant patients to participate in a survey. The eligibility 
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criteria specified that each participant  must be “an attending physician who is up-to-date in the 
care of liver transplant patients.”  All clinicians who agreed to participate were sent a packet 
containing the study instrument, together with a cover letter and an example item.  
Study Instrument
Case reports were prepared based on 16 actual patients who received liver transplants in 
2003-2004 at  Vanderbilt  University Medical Center.  The patients were randomly selected and 
stratified to achieve a balance of good and poor outcomes.  I randomly chose four patients who 
were healthy at  last follow-up, with the original graft intact  (range: 8-18 months after 
transplantation), four patients who experienced a graft failure after 90 days but before 2 years 
after transplantation, and eight patients who experienced a graft failure before 90 days.  
The medical records for the 16 patients were condensed into half-page case reports, fully 
de-identified.  Information was obtained from all available data sources, which consisted of (1) 
electronic medical records, (2) archived paper charts, (3) the local transplant database, and (4) 
UNOS donor and recipient information forms.  Care was taken to include all pre-transplant 
information that  could be relevant to the post-transplant prognosis.  This included (1) basic 
demographic information, (2) history of the liver disease, (3) medical therapy provided, (4) past 
medical and surgical history, (5) family and social history, and (6) characteristics of the donor 
liver.  
To ensure that the reports were readable and concise, only noteworthy information was 
included.  Participants were told to assume that  any findings not  discussed were either within 
normal limits or otherwise unremarkable, given the patient’s health status. For example, the 
finding of “mild encephalopathy” was not repeated in the case report, as this finding is very 
commonly seen in patients with liver failure.  Severe findings like “stage IV hepatic coma,” 
however, were always included in the reports.
For quality control, each case report was independently reviewed by the medical and 
surgical directors of the local liver transplant  program, and by a surgery resident with experience 
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in liver transplant  research.  The three reviewers were asked to evaluate whether the information 
provided was (1) adequate for predicting outcomes, (2) consistent in scope among the reports, and 
(3) objectively described to avoid possible bias by the writer.  An example of a case report is 
shown in figure 9.  
Participants were asked to assess the likelihood of 90-day graft  survival for each patient 
using (1) a 4-point Likert scale of ‘poor’, ‘fair’, ‘good’, or ‘excellent’; and (2) a visual analog 
scale representing the probability of survival.  The participants were also asked to provide their 
age, gender, clinical specialty, and years of experience in caring for liver transplant patients after 
the completion of specialty training.
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History of Present Illness  A 48 year old Caucasian female was diagnosed with hepatitis
C 12 years ago.  Possible infection sources include sexual transmission or IV drug use 25
years ago.  Five years ago she noted decreased energy, shortness of breath, and
intermittent abdominal swelling, and she was diagnosed with cirrhosis.  She did not
respond to interferon.  A TIPS was placed 3 years ago due to persistent ascites and
esophageal varices.  She was listed for transplantation three months later in blood group
O as Status 2B (creatinine 0.6, bilirubin 4.3, INR 1.8).
Past Medical History  Type II diabetes mellitus, obesity with a BMI of 42, mild untreated
hypertension, laparoscopic cholecystectomy, bilateral tubal ligation.
Family & Social History  The patient lives with her four children.  She attended some
college.  Both of her parents have congestive heart failure and diabetes mellitus.  A
cousin had cirrhosis and fatal "liver cancer".  She has a 40 pack year history of smoking
and quit 1 month ago.  Her primary source of payment was private insurance.
Course After Listing  She was admitted 8 months ago with massive refractory ascites and
hypertension.  She also had an episode of spontaneous bacterial peritonitis and vaginal
bleeding.  An ultrasound demonstrated her TIPS to be patent.  Her INR persisted near
2.0, and she received transfusions every few weeks.  She was discharged and awaited
transplantation at home.  A whole liver graft, matched for size and blood type, was
obtained from a 19 year old Caucasian male, deceased by a MVA resulting in intracranial
hemorrhage.  She underwent orthotopic liver transplantation with 13 hours of cold
ischemia time and 39 minutes of warm ischemia time (creatinine 0.6, bilirubin 7.4, INR
2.3).
1) Please circle one subjective assessment of the likely outcome of this transplant:
Poor         Fair         Good         Excellent
2) Please make a single tick mark on the analog scale to represent the probability of
achieving graft survival of at least 90 days:
3) Please fill in your best estimate of the graft survival time:
_______________ Days / Weeks / Months / Years
0% 100%
Likert scale
Visual analog scale
Survival time scale
Clinical summary
Figure 9.  Example of a finished case report.  All case reports were presented using the same structured format. 
Relevant clinical details from the patient’s medical record were summarized and followed by three measurements for 
estimating the prognosis: a 4-point Likert scale, a visual analog scale, and a survival time scale.  The survival time 
scale was not used for any subsequent analysis.  
Statistical Analysis
All statistical analysis was performed using the SPSS package (version 13, http://
www.spss.com).  The mean and standard deviation were calculated for age and years of 
experience of the participating clinicians.  The frequency was calculated for their gender and 
clinical specialty.  For each clinician, the Pearson correlation was computed between predictions 
on the Likert  scale and the visual analog scale.  The distribution of clinician predictions on the 
visual analog scale for each patient  was examined on a box-and-whisker plot and compared with 
the actual outcome of each case.  A t-test  was used to determine whether there was a difference in 
the coefficient of variation in predictions between transplants with good outcomes versus poor 
outcomes.  The ability of each clinician in predicting 90-day graft  survival was measured using 
the AUC, and the 95% confidence intervals were calculated [35].  The AUC is a measure of 
discriminatory power at all classification thresholds, where 0.5 denotes random guessing and 1.0 
denotes perfect discrimination.  The non-parametric Mann-Whitney test  was used to determine 
whether there was a difference in AUC between medical and surgical specialties.  The bivariate 
correlation between years of experience and AUC was computed.  As a baseline for comparison, 
four models from the literature were further validated using the data from the cohort  of 16 
patients. [7,19,23,25] The predictive ability of each model was measured using the AUC.  
Results
Study participation was solicited through a recruitment  email to 150 clinicians.  Study 
material was sent out  to 30 clinicians who agreed to participate, and 20 clinicians returned 
completed surveys (67% response rate; 19 males, 1 female; age 47 ± 6 years).  These clinicians 
represented both medical specialties (n = 4) and surgical specialties (n = 16).  They had 11 ± 6 
years of experience, with a range from 2 years to 21 years.  There was no difference in years of 
experience between the specialty types (p = 0.920).  
The 4-point Likert  scale was used to establish the consistency of predictions for each 
rater between the different metrics.  I examined the correlation between the Likert scale and the 
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visual analog scale, and the median Pearson’s r was 0.86. 
The distributions of the clinicians’ prognostic estimates for 90-day graft  survival are 
shown in figure 10.  Clinicians tended to agree on the prognosis for some patients and disagree 
for others, and no relationship was found between the coefficient of variance and outcome (p = 
0.527).  For cases #3, #5, and #7, clinicians estimated the probability of survival to be 88 ± 8%, 
88 ± 11%, and 88 ± 7% respectively; however, all three of these patients had early graft  failures 
due to post-operative complications.  Two of them had sepsis, leading to death, and one had 
hepatic artery thrombosis, leading to retransplantation.  
One case report (#14) was excluded from AUC performance analysis due to a factual 
discrepancy in the case report discovered after mailing the summaries.  A critical care progress 
note stated that  the patient was not ventilated, as reported in the case summary, but an imaging 
study prior to transplantation noted life support  in place.  The remaining 15 cases were used to 
determine the predictive performance of each clinician, and 13 cases were used for one clinician 
who left two estimates blank.  
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Figure 11.  Distribution of individual clinicians’ discriminatory power.  The area under the receiver operating 
characteristic curve for each clinician is shown, sorted from lowest to highest.  The clinician mean was 0.60 ± 0.16. 
For comparison, the performance of four baseline models for the cohort of 16 patients is shown on the right: Desai, 
0.66; Ghobrial, 0.61; MELD, 0.59; and Thuluvath, 0.45.  
Individual clinicians’ predictive ability for 90-day graft  survival was 0.60 ± 0.16, as 
assessed by the AUC.  This was comparable to the performance of published models for my 
cohort of patients (MELD 0.59; Desai 0.66; Ghobrial 0.61; Thuluvath 0.45), as shown in figure 
11.  The confidence intervals for all AUC calculations were wide, by roughly 50%, due to the 
small number of patients represented in each receiver operating characteristic curve.  
There was no difference in predictive ability between the medical specialties and the 
surgical specialties (p = 0.570).  A significant  negative correlation (r = -0.641, p = 0.003) was 
found to exist between years of experience and predictive power, illustrated by figure 12.  
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Figure 12.  Correlation between experience and discriminatory power.  Experience was defined by the number of 
years a clinician spent caring for liver transplant patients as an attending physician.  Discriminatory power was 
measured by the area under the receiver operating characteristic curve.  A significant negative correlation was found, 
r = -0.641, p = 0.003.
Discussion
A few observations were noted regarding the distribution of clinician predictions for each 
case.  There were patients about whom clinicians tended to agree, and other patients about whom 
the clinicians tended to disagree.  Furthermore, when clinicians agreed in their predictions for a 
given patient, the consensus opinion was not always correct, as shown by cases #3, #5, and #7. 
The patients with good predicted survival and poor actual survival tended to experience 
complications of generalized sepsis or hepatic artery thrombosis.  These complications may be 
very difficult  to predict based on pre-transplant  information.  Other researchers have postulated 
that there is a theoretical limit  on how well a pre-transplant  model of liver transplant survival can 
perform, because certain complications are affected by peri-operative and early post-operative 
events [25,36,67].  My observations are consistent with this suggestion.  
The results indicate that clinicians predict 90-day graft  survival after liver transplantation 
with a mean AUC performance of 0.60.  As a baseline for performance, models in the literature 
showed similar or worse performance than the clinicians.  The statistical significance of this trend 
was not  evaluated, because the confidence intervals were wide for the AUC estimates.  
The patient  population was selected randomly and stratified to attain a balance of good 
and poor outcomes.  The prevalence of severe complications was higher in my population than in 
the overall population of patients receiving liver transplants.  Considering this, if it  holds true that 
certain complications of liver transplantation are inherently hard to predict, then it logically 
follows that the predictive ability of a model should be lower with my limited population than 
with the general population.  This is substantiated by the fact that  the four published models all 
showed worse performance than reported in the literature. 
The results indicated that  less-experienced clinicians have better predictive ability than 
their more experienced colleagues.  At the present time, I can only speculate about  potential 
explanations for this rather surprising finding.  It  is possible that more experienced clinicians take 
on more administrative duties as their careers progress, and hence they spend less time with 
patients.  Likewise, it  is possible that  more experienced clinicians were busier and thus were 
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unable to devote as much time and attention to the survey as their less experienced colleagues. 
There could also be a bias in the group of participants or in the study instrument that  contributed 
to this finding.  However, this incidental finding requires further examination to distinguish 
between these possible hypotheses, and future research will focus on this issue.  
The study has limitations that merit discussion.  First, I have a relatively small sample 
size of participants.  Based on the trends observed in the data analysis, some statistically 
significant effects were found, and the trends that  were not  significant were deemed unlikely to 
become significant  if the sample size were increased.  Second, I have a small number of cases 
evaluated by each clinician, resulting in the confidence intervals of AUC performance 
calculations being relatively wide.  To achieve an adequate return rate, I limited the number of 
cases included, as it  took 30 minutes to an hour for the clinicians to read through and make 
predictions for the 16 included cases.  To further increase the number of cases would ask for an 
impractical time commitment  on the part  of the attending physicians who completed the survey. 
Third, the participants in the study never saw firsthand the patients they were assessing; all of the 
predictions were based on written case reports.  The manner of presentation of the case reports 
may have been an important  influence on clinician predictions.  However, the preparation of these 
case reports included a quality control step in anticipation of this limitation, and great  efforts were 
made to include all relevant information in the summaries.  
Conclusion
Based on the survey data, the overall ability of clinicians to predict  survival for a set of 
pre-transplant scenarios was similar to published survival models.  In other words, their power to 
discriminate between likely survivors and non-survivors was relatively modest.  Our data are 
consistent with the postulate that certain post-operative complications of liver transplantation may 
be inherently hard to predict  prior to surgery.  
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CHAPTER VIII
CONCLUSION AND POLICY IMPLICATIONS
The greatest practical value in a liver transplant survival model lies in its ability to make 
predictions at or before the time of transplantation.  Others have shown that it is possible to 
predict liver transplant  survival with good accuracy if post-transplant information is considered 
[18,67].  However, the utility of a post-transplant  model is mitigated by its inability to make 
predictions at the time of decision-making.  Because of this, my thesis has focused on the harder 
and more clinically-oriented problem of developing a pre-transplant survival model.  
To address Specific Aim 1, Chapter IV showed that  a Bayesian network can be created to 
predict liver transplant  survival with performance that  exceeds published Cox regression models 
using an independent UNOS data set.  Chapter VI demonstrated that a support vector machine 
can be scaled up to learn a survival model using a very large set of data.  
To address Specific Aim 2, Chapter V illustrated that fully automated feature selection 
techniques can identify the key predictors of liver transplant  survival within a very large database, 
and this predictor set  performed better than two out of three published in the literature.  Chapter 
VI showed that a relatively simple model that  accounts for main effects and two-way variable 
interactions may be sufficient for predicting liver transplant survival with the UNOS database.  
To address Specific Aim 3, Chapter VII described the ability of clinicians to predict 
survival after liver transplantation.  They perform similarly to mathematical models using our 
survey cohort, so careful evaluation is necessary if a decision support  system is to be used in 
transplantation.  
In addition to addressing the Specific Aims, these collective results highlight the fact that 
predicting survival after liver transplantation is a challenging problem.  Others have suggested 
that there is a theoretical limit on how well a pre-transplant model can perform [25,36,67].  Two 
lines of reasoning support this idea.  First, model performance may be limited by the content of 
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the data available, as shown by my extensive search of the UNOS database.  Second, the 
observations from the clinician survey suggest that certain complications of liver transplantation 
are inherently hard to predict.  My thesis, however, does not address where the theoretical limit 
may be, or how close the current  survival models are to reaching that  limit.  
These findings carry policy implications that pertain both to clinical decision support and 
to the collection of transplant data.   First, my Bayesian network, which was validated using an 
independent  data set and showed generalizable performance, may be useful for clinical decision 
support  in transplantation.  I emphasize that it  should be used as an adjunct, and not as a 
replacement, for clinical judgment.  Clinicians should be made aware of the strengths and 
weaknesses of the model, and care should be taken to monitor the impact of its implementation. 
Second, the collection of additional data pertaining to transplantation may be warranted.  For 
example, these data may include the viral genotype of hepatitis C, a gene expression profile of 
hepatocellular carcinoma, or mass spectrometry analysis of the donor liver.  
In summary, accurate survival prediction after liver transplantation is challenging, and it 
remains an open problem.  However, I have proposed a model for liver transplant survival, and I 
have carefully validated and compared its performance to models from the literature.  I have 
characterized various aspects of the problem, including which predictors are important, and how 
complex should a model be in considering them.  I have also investigated the ability of clinicians 
to predict survival, which is the current standard of care for making decisions in transplantation. 
These elements together pave the way for future refinements in survival modeling, and for a 
clinical trial of decision support  in liver transplantation.  
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APPENDIX A
DETAILS ON CLEANING THE UNOS DATABASE
Several steps of processing occurred in order to convert the UNOS liver transplant 
database into a cleaner form that  would be more useful for survival modeling.  These steps are 
detailed below. 
1. Validation of Data Elements.  The format of data was validated, and all invalid items were 
removed from the database.  All free-text  variables were considered to be valid.  For all other 
variables, the following values were deemed to be missing:
a. Any values which were blank or ‘**’, or which contained a question mark
b. Any date values which did not have the format  MM/DD/YYYY
c. Any time values which did not have the format HH:MM:SS
d. Any numeric values which did not  have a valid decimal representation
e. Any values which are connected to text labels in an external file, for which there was no 
label defined
2. Ambiguous Information.  All values which represented complete uncertainty, and thus 
contained no useful information for the present  purposes, were removed from the database. 
The following values were deemed to be missing:
a. All of the ‘U’ values for character discrete variables, which often take the form ‘Y/N/U’ 
or ‘P/N/U’
b. Any of the values ‘Cannot Disclose’, ‘Indeterminate’, ‘Not Done’, or ‘Unknown’ for 
variables which denoted serum status, as noted by SERSTAT  labels
c. For other discrete variables, any of the values ‘Unknown’, ‘UNKNOWN’, ‘Unknown 
Duration’, ‘Not  Reported’, ‘Confirmed Blk.’, ‘Not  Tested’, or ‘Unknown (for Donor 
Referral only)’
d. For the variables ABO and ABO_DON, the value ‘UNK’
e. For the variable PX_STAT, the value ‘N’
3. Range Checking.  For continuous variables, a range was established for values which would 
be considered reasonable.  Any values falling outside of this range were removed from the 
database, as they resulted either from data entry errors or extreme outliers.  The following 
ranges were established for continuous data:
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a. Age: 0 - 100 years
b. Height: 25 - 250 cm
c. Weight: 2.5 - 250 kg
d. Albumin: 0.5 - 7.5 g/dl
e. Alkaline phosphatase: 20 - 2500 U/l
f. Blood urea nitrogen: 5 - 150 mg/dl
g. Creatinine: 0.2 - 10 mg/dl
h. Prothrombin time: 5 - 75 sec
i. Prothrombin control time: 5 - 50 sec
j. International normalized ratio: 1 - 20
k. Transaminases: 5 - 30000 U/l
l. Total bilirubin: 0.2 - 75 mg/dl
m. Cold ischemia: 0 - 48 hours
n. Warm ischemia: 5 - 240 minutes
o. Variables which cannot  be non-negative: > 0
p. Dates: > 1/1/1985
q. Year of transplantation: > 1985
4. Category Abstraction.  Discrete variables which had a large number of possible categories, 
and thus an insufficient number of values in each category for reliable statistical testing, were 
condensed into broader categories.  The following substitutions were made:
a. ABO blood type: the values ‘A’, ‘A1’, and ‘A2’ were all marked as ‘A’, and the values 
‘AB’, ‘A1B’, and ‘A2B’ were all marked as ‘AB’
b. Cancer site: all values other than ‘NO’ were marked as ‘YES’
c. Storage solution: any values aside from ‘VIASPAN (UW/BELZER)’ were marked as 
‘OTHER’
d. Ethnic category: the ‘Non-Hispanic Multiracial’ designation was made part  of the ‘Other’ 
category
e. Time zone: the values ‘ALASKA’, ‘HAWAII’, and ‘ATLANTIC’ were combined into a 
category called ‘OTHER’
f. Payment source: all values aside from ‘HMO/PPO’, ‘MEDICAID’, ‘MEDICARE’, and 
‘PRIVATE INSURANCE’ were grouped into a category called ‘OTHER’
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g. Employment  status: all values designating some reason for not  working were marked as 
‘NOT  WORKING’, and all values designating some reason for working part time were 
marked as ‘WORKING PART TIME’
h. Patient status: all values other than ‘LI: Status 1’ were marked as ‘OTHER’
i. States: all values were combined into their respective UNOS regions, as defined by the 
OPTN at http://www.optn.org/latestData/stateData.asp?type=region.  
j. Diagnosis: all values were combined into the categories ‘NON_CHOLESTATIC’, 
‘CHOLESTATIC’, ‘ACUTE_HEPATIC_NECROSIS’ , ‘METABOLIC’, 
‘MALIGNANT’, ‘BILIARY_ATRESIA’, and ‘OTHER’, as defined by the OPTN at 
http://www.optn.org/organDatasource/about.asp?display=Liver.
5. Calculated Variables.  A few custom variables were calculated and added into the database. 
Their values were determined using the following methods:
a. Patient survival at 30 days, 90 days, 6 months, 1 year, and 5 years: this variable took the 
value ‘Y’ if patient  observation time was greater than the desired interval, ‘N’ if patient 
observation time was less than the desired interval and the patient status was marked as 
dead, and it  was marked as missing otherwise
b. Graft survival at  30 days, 90 days, 6 months, 1 year, and 5 years: this variable took the 
value ‘Y’ if graft  observation time was greater than the desired interval, ‘N’ if graft 
observation time was less than the desired interval and the patient status was marked as 
dead or retransplanted, and it  was marked as missing otherwise
c. Body mass index for the donor and recipient: this was determined by the formula (weight 
in kg / (height in m) squared), and any values less than 5 or greater than 100 were 
considered absurd and thus marked as missing
d. Gender match combination: this variable took one of the values ‘FF’, ‘FM’, ‘MF’, or 
‘MM’, representing the concatenation of donor and recipient  gender, respectively
6. Uncleaned Variables.  The following variables were not  cleaned and should be excluded from 
further analysis.  The rationale for excluding these items is described below.  
a. DA1, DA2, DB1, DB2, DDR1, DDR2, RA1, RA2, RB1, RB2, RDR1, RDR2: these 
histocompatibility variables have too many categories and could not  be condensed in a 
systematic manner, and the variables AMAT, AMIS, BMAT, BMIS, DRMAT, and 
DRMIS act as appropriate surrogates for them
b. All binary payment form variables (DONATION_*, FREE_*, HMO_PPO_*, 
MEDICAID_*, MEDICARE_*, OTH_GOVT_*, PRIV_INS_*, SELF_*): these were 
removed because the PRIMPAY variables act as surrogates for them
c. DEATH_MECH_DON, DIAL_TY_TCR, HIST_DIABETES_DON, LITYP, RACE, 
RACE_DON, TX_PROCEDUR_TY: these variables would all need to have their 
categories condensed for proper analysis, and those condensed variables already exist  in 
the database
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d. CLSTR_OLD, CLSTRTYP_OLD, EXTRACRANIAL_CANCER_DON, ECMO, IABP, 
LI_PUMP, PGE, VAD_TAH: these items lack sufficient variation to be useful for 
statistical tests
e. CMV_OLD, HBEAB_OLD, HEPD_OLD, HIV_CONF_CAD_DON, 
HIV_SCRN_CAD_DON, MRCREATG_OLD: collection of these variables stopped 
during the study interval, and thus they are not populated for prospective validation
7. Identification of Pre-Transplant Variables.  The following steps were used to eliminate items 
and reduce the UNOS data to those variables that  were available prior to transplant.
a. Variables collected on the forms TRF or TRF/TRR
b. Variables marked as TRR/TRF - CALCULATED
c. Variables collected on the form TRR in the section POST  TRANSPLANT CLINICAL 
INFORMATION
d. Encrypted identifiers
e. Items for internal UNOS use (DATASET, DATE_OF_RUN)
f. Other outcome variables (GTIME, GSTATUS, PTIME, length of stay variables including 
DISCHARGE_DATE)
g. Items with OSTXT in the title
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